Literature DB >> 10648499

Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease.

J W Sayer1, B Marchant, S V Gelding, J A Cooper, A D Timmis.   

Abstract

OBJECTIVE: To assess the role of beta cell failure in the development of autonomic dysfunction in patients with coronary artery disease.
DESIGN: Autonomic function was measured by standard clinical methods and by heart rate variability in 24 type II diabetic and 24 non-diabetic subjects with coronary artery disease. Quantitative estimates of pancreatic beta cell function (%beta) and insulin resistance were made from basal plasma glucose and insulin concentrations using a computer solved model. Fasting proinsulin levels provided an independent measure of beta cell function.
RESULTS: The circadian rhythm of sympathovagal balance (ratio of low to high frequency spectral components of heart rate variability) was significantly attenuated in patients with below median (%beta </= 63. 3) compared with above median pancreatic beta cell function. Multiple measures of autonomic function showed positive associations with %beta (low frequency: r = 0.41, p = 0.004; high frequency: r = 0.27, p = 0.07; lying/standing fall in systolic pressure: r = -0.30, p = 0.04) and negative associations with proinsulin (low frequency: r = -0.35, p = 0.03; high frequency: r = -0.36, p = 0.02; standard deviation of RR intervals: r = -0.43, p = 0.007). Associations tended to be stronger in non-diabetic than diabetic patients. In contrast, there was no association between insulin resistance and either autonomic function or the circadian rhythm of sympathovagal balance, regardless of diabetes status.
CONCLUSIONS: The data are consistent with the hypothesis that beta cell failure plays a pathogenic role in the development of autonomic dysfunction in patients with coronary artery disease.

Entities:  

Mesh:

Year:  2000        PMID: 10648499      PMCID: PMC1729315          DOI: 10.1136/heart.83.2.210

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  Frequency domain measures of heart period variability and mortality after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; R E Kleiger; J N Rottman
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

Review 2.  Insulin resistance syndrome: possible key role of blood flow in resting muscle.

Authors:  P O Ganrot
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

3.  The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.

Authors:  D K Nagi; T J Hendra; A J Ryle; T M Cooper; R C Temple; P M Clark; A E Schneider; C N Hales; J S Yudkin
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

4.  Detection of silent myocardial ischemia in diabetes mellitus.

Authors:  A Langer; M R Freeman; R G Josse; G Steiner; P W Armstrong
Journal:  Am J Cardiol       Date:  1991-05-15       Impact factor: 2.778

5.  Relation between heart rate variability early after acute myocardial infarction and long-term mortality.

Authors:  S Vaishnav; R Stevenson; B Marchant; K Lagi; K Ranjadayalan; A D Timmis
Journal:  Am J Cardiol       Date:  1994-04-01       Impact factor: 2.778

6.  Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes.

Authors:  B Marchant; V Umachandran; R Stevenson; P G Kopelman; A D Timmis
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

7.  Frequency domain measures of heart period variability to assess risk late after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; L M Rolnitzky; R C Steinman
Journal:  J Am Coll Cardiol       Date:  1993-03-01       Impact factor: 24.094

8.  Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.

Authors:  S M Haffner; L Mykkänen; M P Stern; R A Valdez; J A Heisserman; R R Bowsher
Journal:  Diabetes       Date:  1993-09       Impact factor: 9.461

9.  Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease.

Authors:  L Bernardi; L Ricordi; P Lazzari; P Soldá; A Calciati; M R Ferrari; I Vandea; G Finardi; P Fratino
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

10.  Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.

Authors:  M J Davies; J Metcalfe; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

View more
  3 in total

1.  Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transBATation).

Authors:  Zheng Zhu; Elizabeth G Spicer; Chaitanya K Gavini; Ashley J Goudjo-Ako; Colleen M Novak; Haifei Shi
Journal:  Physiol Behav       Date:  2013-11-27

2.  Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study.

Authors:  J Kronborg; S H Johnsen; I Njølstad; I Toft; B O Eriksen; T Jenssen
Journal:  Diabetologia       Date:  2007-06-09       Impact factor: 10.122

3.  Circadian Pattern of Acute Myocardial Infarction and Atrial Fibrillation in a Mediterranean Country: A study in Diabetic Patients.

Authors:  Stylianos Daios; Christos Savopoulos; Ilias Kanellos; Christos Argyrios Goudis; Ifigeneia Nakou; Stergiani Petalloti; Nicolas Hadjidimitriou; Dimitrios Pilalas; Antonios Ziakas; Georgia Kaiafa
Journal:  Medicina (Kaunas)       Date:  2021-01-06       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.